Galveston Bay Personal Injury Lawyer articles in category: FDA & Prescription Drugs

Two weeks after Actavis issued a recall for its heart medication Digitek, or digoxin, the first lawsuits have been filed. Very little information has been made available on this recall other...

A new lawsuit has been filed against Bayer in response to the controversy currently surrounding Trasylol. This lawsuit however does not make a personal injury claim against the company, as...

Yesterday after hearing the stories of families that lost loved ones that were treated with contaminated Heparin, Rep. John Dingell said, “Our citizens can no longer trust that their food,...

A new study suggests that women treated with Fosomax to combat the symptoms of osteoporosis are twice as likely to develop a common form of irregular heartbeat known as atrial fibrillation...

According to Reuters the German pharmaceutical giant Bayer is facing 78 lawsuits in the United States involving the anti bleeding drug Trasylol. Last November Bayer suspended marketing of...

Over the past few years, scientists have had extremely high aspirations for a new category of medications used to treat addiction. The medications work in a new way to eliminate cravings by...

The FDA has announced that they now believe that the ingredient found in tainted lots of Baxter’s Heparin was most likely not a mistake. The compound, a heparin-like substance identified last month...

A report published in today’s Journal of the American Medical Association (JAMA) makes accusations that Merck, one of the world’s most powerful and influential pharmaceutical companies,...

This week the FDA launched an investigation into an increased risk of cancer and death that may be associated with the Johnson & Johnson foot gel, Regranex. The foot gel, approved by the FDA in 1997, is used to treat leg and foot wounds most commonly associated with diabetes. A study found an increase in the number of cancer deaths among patients who had been prescribed the medication three or...

A federal judge has dismissed the case of a 25 year-old California man who charged the cockpit of a plane on Thanksgiving forcing an emergency landing in Fargo, North Dakota. Prosecutors asked for the interfering with an airplane flight crew charge to be dropped against Andrew Smith after psychiatric exam revealed that Smith was suffering from psychotic disorder caused by Pfizer's smoking...

Three weeks into the trail, yesterday it was announced that Eli Lilly has agreed to pay $15 million to settle a lawsuit brought by the state of Alaska over the popular antipsychotic medication Zyprexa. The lawsuit alleged that Zyprexa caused patients to develop diabetes after taking the medication. The state was seeking to recover Medicaid money spent on both the medication itself and the...

This week Amgen and Wyeth updated the warning label for their rheumatoid arthritis medication, Enbrel, to inform healthcare professionals and patients of an increased risk of infection associated with the drug. The drug already carried a risk of infection warning; however, the update expands this warning to include information about screening and monitoring patients for tuberculosis (TB). In...

This week a Pennsylvania judge ruled that federal law cannot preempt a state product liability lawsuit regarding GlaxoSmithKline's antidepressant Paxil. The ruling was centered on the alleged failure of GSK to warn patients and healthcare professionals about an increased risk of suicide associated with the medication. Judge Allan L. Tereshko concluded that federal preemption does not prohibit...

Today the FDA informed health care professionals of life-threatening adverse events and death in patients taking Tussionex Pennkinetic Extended Release Suspension. According to the FDA website doctors have prescribed the hydrocodone containing cough suppressant to children under the recommended age of six. Additional reports of physicians prescribing the medication at more frequent intervals...

Last Friday the FDA added the strictest warning available to three anemia medications. The black box warning warns of an increased risk of death and tumor growth associated with the medications. Amgen's Aranesp and Epogen and Johnson & Johnson's Procrit have been shown to accelerate tumor growth in patients with several different types of cancer. The drugs had been linked to similar risks in...